Loading...
PhD Jurij Trontelj

PhD Jurij Trontelj
no.: 23420 source: ARIS

researcher – active in research organisation
Phone number 01 475 95 00
E-mail jurij.tronteljat signffa.uni-lj.si
Foreign language skills
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
Biopharmacy, pharmacocinetics, pharmacogenomics
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
623.78
A''
171.93
A'
337.26
A1/2
457.3
CI10
1,046
CImax
106
h10
18
A1
2.29
A3
1.36
Data for the last 5 years (citations for the last 10 years) on April 24, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 71  1,193  1,033  14.55 
Scopus 68  1,261  1,101  16.19 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Andrej Grobin  Bologna doctoral studies  10/1/2018 - 9/30/2022  52093 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2002 
Doctor's degree  Ph. D.     SI University of Ljubljana, Faculty of Pharmacy 2007 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position ecris.org.employ_rolegroup Title
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair of Pharmaceutical Technology  1/1/2003  Assistant  Researcher  Assistant professor 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  6,050 
2. J2-4480  Removal of selected antimicrobials by plasma-cavitation hybrid technology from water matrices of varying complexity (Causma)   2022 - 2024  PhD Martin Petkovšek  2,693 
3. L1-3160  Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration   2021 - 2024  PhD Iztok Grabnar  2,929 
4. J1-3030  MTAvsAMR: new MultiTargeting Antibiotics against AntiMicrobial Resistance   2021 - 2024  PhD Lucija Peterlin Mašič  955 
5. L3-3177  Safety evaluation of cannabidiols and implications for public health and consumers behaviour   2021 - 2024    4,833 
6. J3-2517  Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants   2020 - 2023  PhD Žiga Jakopin  2,205 
7. J3-9256  Development of NOD2 agonists and dual NOD2/TLR7 agonistic conjugates as novel vaccine adjuvants   2018 - 2022  PhD Žiga Jakopin  2,803 
8. V3-1636  New psychoactive substances monitoring system in Slovenia (acronym SONDA)   2016 - 2018  PhD Miran Brvar  1,488 
9. J1-6744  Development of Molecularly Imprinted Polymers and their application in environmental and bio-analysis   2014 - 2017  PhD Tina Kosjek  4,810 
10. J3-4313  The influence of active transport and patients' genotypes on the therapeutic outcome of chronic myeloic leukemia   2011 - 2014  PhD Albin Kristl  3,120 
11. J1-0957  Pharmacogenetic study of raloxifene metabolism and transport   2008 - 2011  PhD Aleš Mrhar  1,948 
ARIS research and infrastructure programmes Legend
source: ARIS
Views history
Favourite